• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

Out-of-Pocket Healthcare Expenditures in the United States

$4,000.00 – $8,000.00

This report estimates U.S. consumer out-of-pocket spending on healthcare, particularly direct payments to providers and financed payments.

Clear
SKU: 19-032 Categories: Healthcare Market Research, Insurance & Managed Care Tags: Consumer Out-of-Pocket Expenditures, Direct Pay and Co-Pay Expenditures, Elective Healthcare Expenses, Non-Elective Healthcare Expenses, Out-of-Pocket Healthcare Spending, Specialized Healthcare Financing Pages: 214
  • Description
  • Table of Contents
  • Latest reports

Description

A variety of demographic, business, and government trends are contributing to rising out-of-pocket (OOP) healthcare expenses in the United States. Out-of-Pocket Healthcare Expenditures in the United States examines these trends in detail, focusing on the financial aspects of OOP spending growth and quantifying the growth of OOP spending with forecasts of total expenditures and specialized healthcare financing.

Total Expenditures

The report examines past, current, and future levels of U.S. out-of-pocket healthcare expenditures both in total and as specific sub-groups (by type, by payment method, by elective vs. non-elective). Through the next five years, total consumer out-of-pocket expenditures for healthcare are expected to continue rising, with trends established over the past several years continuing through the foreseeable future. The report presents the following data points:

  • Growth of Consumer Out-of-Pocket Expenditures 2014 – 2024, in $ Billion
  • How Consumer Out-of-Pocket Expenses Are Financed in 2019 (%) (Credit Cards, Cash or Check, FSAs, Loans or Lines of Credit, Healthcare Financing, HSAs)
  • Consumer Out-of-Pocket Expenditures Paid with Specialized Healthcare Financing 2014 – 2024, in $ Billion

Types and Amounts of Expenses Financed

In 2019, U.S. consumers financed many different types of healthcare expenses; these can broadly be grouped into two categories: elective procedures including over-the-counter (OTC) medications and non-elective procedures including prescription drugs. These types of procedures are distinct, and discussed separately within the report.

Elective procedures are those that are not strictly necessary to address a medical condition. They are thus not covered by medical insurance and their utilization is discretionary on the part of the consumer. The amount of non-elective healthcare and prescription drug expenses financed by individual consumers varies widely, although a very large proportion of consumers must finance some expenditures. The report provides the following data:

  • Methods of Financing Elective Procedures, 2018 (Credit Cards, Cash or Check, Healthcare Financing Programs, Loans or Lines of Credit)
  • Average Share of Non-Elective Healthcare Expenses Paid Out-of-Pocket by Percentile of Total Health Spending, 2018 (Top 1st, 1st to 5th, 5th to 10th, 10th to 20th, Lowest 80th)
  • Average Share of Non-Elective Healthcare Expenses Paid Out-of-Pocket by Type of Service, 2018 (Hospital, Outpatient, Office Based Visit, Prescription Drugs, Emergency Room, Dental, Home Health, Vision, Other Health Care)
  • Average Share Paid Out-of-Pocket by U.S. Residents by Percentile of Total Health Spending and Type of Service, 2018 (in top 5%: Hospital, Outpatient, Office Based Visit, Prescription Drugs, Emergency Room, Dental, Home Health, Vision, Other Health Care; in top 10% to 5%: Hospital, Outpatient, Office Based Visit, Prescription Drugs, Emergency Room, Dental, Home Health, Vision, Other Health Care; in top 20% to 10%: Hospital, Outpatient, Office Based Visit, Prescription Drugs, Emergency Room, Dental, Home Health, Vision, Other Health Care; in bottom 80%: Hospital, Outpatient, Office Based Visit, Prescription Drugs, Emergency Room, Dental, Home Health, Vision, Other Health Care)
  • Distribution of Out-of-Pocket Healthcare Spending for the Average Person, 2018 (Hospital, Outpatient, Office Based Visit, Prescription Drugs, Emergency Room, Dental, Vision, Other Health Care)
  • Drug Cost Coverage by Payor Type (Public, Private, Cash) 1965, 1985, 2000, 2005, 2010, 2018

Consumers Who Pay Out-Of-Pocket

Consumers from all socioeconomic groups are facing high out-of-pocket expenditures for healthcare. Certain groups are more vulnerable than others to having trouble paying their medical bills and represent a larger proportion of this spending. These include the uninsured and underinsured, Medicaid recipients, disabled persons, senior citizens, the mentally ill, obese persons, people suffering from drug or alcohol addiction, persons with chronic medical conditions. Out-of-Pocket Healthcare Expenditures in the United States provides the following related information:

  • Size of High Risk Groups for Out-of-Pocket Healthcare Expenditures, 2014 – 2024, in Millions of Persons (The Uninsured & Under-insured, Medicaid Recipients, The Disabled, Senior Citizens, The Mentally Ill, The Obese, Persons with Drug or Alcohol Addictions, Persons with Chronic Conditions)
  • Comparative Sizes of High Risk Groups for Out-of-Pocket Healthcare Expenditures, 2014 – 2024, in Millions of Persons (The Uninsured & Under-insured, Medicaid Recipients, The Disabled, Senior Citizens, The Mentally Ill, The Obese, Persons with Drug or Alcohol Addictions, Persons with Chronic Conditions)
  • Obesity in the United States, 1980 – 2024 (U.S. Population [Millions], Percentage Obese, Number Obese [Millions])
  • Proportion of Adults under Age 65 with Chronic Conditions, 2018 (Privately Insured, Medicare or Medicaid, Uninsured, Other)

Expenditures by Type, Payment Methods, Elective vs. Non-Elective Procedures

Consumers in the United States utilize a variety of methods to pay for healthcare products and services, required in instances when payment is not made directly from a healthcare plan to the provider. The report examines expenditure by type, including direct payments and co-pays, and illustrates that the amount of out-of-pocket expenditures financed by consumers in the coming years will vary considerably between elective and non-elective procedures. Featured data include:

  • Change in Consumer Out-of-Pocket Expenditures by Type 2014 – 2024, in $ Billion (Direct Payments, Co-pays, Total, Change [%])
  • Proportion of Consumer Out-of-Pocket Spending by Type of Healthcare Expenditure, 2014, 2019, 2024 (Direct Payments, Co-pays)
  • Change in Consumer Out-of-Pocket Expenditure by Payment Type, 2014 – 2024, in $ Billion (Credit Cards, Cash or Check, FSAs, Loans or Lines of Credit, Healthcare Financing Programs, HSAs, Total, Change [%])
  • Proportion of Consumer Out-of-Pocket Expenditures by Payment Type, 2014, 2019, 2024 (Credit Cards, Cash or Check, FSAs, Loans or Lines of Credit, Healthcare Financing Programs, HSAs)
  • Growth of Consumer Out-of-Pocket Expenditures for Elective vs. Non-Elective Procedures, 2014 – 2024, in $ Billion (Elective, Non-Elective)
  • Change in Consumer Out-of-Pocket Expenditures for Elective Procedures That Are Financed, by Payment Type, 2014 – 2024, in $ Billion (Paid by Cash or Check, Financed, Total, Change [%])
  • Proportion of Consumer Out-of-Pocket Spending for Elective Procedures That Are Financed (All Methods), 2014, 2019, 2024 (Paid by Cash or Check, Financed)
  • Change in Amount of Consumer Out-of-Pocket Expenditures for Non-Elective Procedures That Are Financed, 2014 – 2024, in $ Billion (Paid by Cash or Check, Financed, Total, Change [%])
  • Proportion of Consumer Out-of-Pocket Spending for Non-Elective Procedures That Are Financed (All Methods), 2014, 2019, 2024 (Paid by Cash or Check, Financed)
  • Distribution of Out-of-Pocket Spending on Non-Elective Procedures for the Average Person, 2013 (Ill-defined conditions, Circulatory, Musculoskeletal, Respiratory, Endocrine, Nervous system, Cancers, Injury, Genitourinary, Digestive, Mental Illness, Other, Infectious diseases, Pregnancy and childbirth, Dermatological)

Market Drivers and Restraints

The strong growth in U.S. out-of-pocket spending is the result of a preponderance of market drivers, which are mitigated by relatively few market restraints. The report shows leading drivers and restraints of consumer out-of-pocket healthcare spending, in order of strength, across the market:

  • Drivers & Restraints of the Consumer Out-of-Pocket Spending Market
  • Drivers & Restraints of Direct Pay and Co-Pay Expenditures
  • Drivers & Restraints of Credit Cards, Cash/Check, FSA, Loan/Line of Credit, Healthcare Financing Program and HSA Expenditures
  • Drivers & Restraints of Elective Procedure Out-of-Pocket Expenditures
  • Drivers & Restraints of Non-Elective Procedure Out-of-Pocket Expenditures
  • Drivers & Restraints of Specialized Healthcare Financing
  • Drivers & Restraints of Specialized Healthcare Financing for Elective Procedures
  • Drivers & Restraints of Specialized Healthcare Financing for Non-Elective Procedures

Company Profiles

A large number of companies help consumers pay their out-of-pocket medical expenses and/or significantly influence those expenses. Most companies that provide patient financing focus on funding elective procedures, with a smaller number offering financing for non-elective therapies and providing other financial services. While companies participating in the credit card, and lines/lines of credit segment are numerous and do not specialize in healthcare products, the companies operating in the specialized healthcare financing are highly focused on financing medical and dental expenses. In general, the market is very dynamic, with many players entering and exiting. Out-of-Pocket Healthcare Expenditures in the United States provides profiles of players in the market, noting history and lines of business, financial information, and relevant business operations. The companies profiled include:

  • Ajeva
  • Aurora Quick Care
  • CareCredit
  • CareSpot
  • ClearBalance
  • ClearGage
  • Concentra
  • Denefits
  • E-Financing Solutions
  • FastMed
  • Lending Club Patient Solutions
  • LendingUSA
  • MinuteClinic
  • NextCare
  • PatientFi
  • Prosper Healthcare Lending
  • RediClinic
  • Reliance Medical Financial
  • SimpleSelect Patient Finance
  • U.S. HealthWorks
  • Wells Fargo

 

Because this report focuses on consumers, excluded are healthcare expenses related to employers, manufacturers, providers, and payers. Excluded from forecasts are healthcare premiums paid to healthcare plan sponsors or employers. Spending estimates are expressed in current U.S. dollars. Estimates are provided for the historic 2014 to 2019 period and forecasts are provided through 2024.

Table of Contents

Chapter 1: Executive Summary

  • Out-of-Pocket Expenditures in the U.S. Healthcare Industry
  • Scope and Methodology
  • Out-of-Pocket Spending Summary
    • Exhibit 1-1: Total U.S. Out-of-Pocket Spending Growth, 2014 – 2024
    • Exhibit 1-2: Consumer Out-of-Pocket Spending Market Drivers and Restraints
    • Exhibit 1-3: How Consumer Out-of-Pocket Expenses Are Financed in 2019 (%) (Credit Cards, Cash or Check, FSAs, Loans or Lines of Credit, Healthcare Financing, HSAs)
    • Exhibit 1-4: Consumer Out-of-Pocket Expenditures Paid with Specialized Healthcare Financing 2014 – 2024, in $ Billion

Chapter 2: The U.S. Healthcare System in 2019

  • Healthcare System Overview
  • Public Healthcare
  • Private Healthcare
  • On Demand Healthcare
  • Insufficient Focus on Wellness and Prevention
  • Cost Issues
    • Exhibit 2-1: Percent of U.S. National Healthcare Spending by Category, 2019 (Hospital Care, Physician and Clinical Services, Retail Sales of Medical Products, Prescription Drugs, Long-term Care Including Nursing Care, Dental Services)
  • Healthcare Inflation
  • Managed Care Cost Shifting
  • Balance Bills
  • Physician Shortages
  • System Errors and Inefficiencies
  • The Effect of the Economy
    • Exhibit 2-2: Key U.S. Economic Strength Measures, March 2019 (Inflation Rate, Unemployment Rate, Median Household Income, Poverty Rate, Household Debt, Household Debt per Capita, Consumer Confidence)
  • Widening Wage Gap
  • Disease Management and Wellness Programs
  • Regulation
    • Exhibit 2-3: Selected U.S. Federal and State Healthcare Oversight Bodies, 2019
  • Reimbursement Challenges
  • Consumer Healthcare Information
  • Consumer Information Online
  • DTC Ad Spending
  • Personal Health Records (PHRs)
  • Lower Cost Medications
  • Generic Drugs
  • Private-Label OTC Medications
  • Rx-to-OTC Switches
  • Medical Tourism
  • Affordable Care Act
  • Individual Mandate Repeal
  • Association Health Plans
  • Short Term Limited Duration Insurance (STLDI)
  • Further Changes to the ACA

Chapter 3: U.S. Out-of-Pocket Expenditures

  • Types of Expenditures
  • Insurance Co-Payments
  • Direct Payments
  • Premiums and Plan Fees
  • Payment Methods
  • Cash or Check
  • Credit Cards
  • Loans and Lines of Credit
  • Medical Financing
  • Flexible Spending Accounts
  • Health Savings Accounts
  • Types and Amounts of Expenses Financed
  • Elective Procedures and OTC Medications
    • Exhibit 3-1: Methods of Financing Elective Procedures, 2018 (Credit Cards, Cash or Check, Healthcare Financing Programs, Loans or Lines of Credit)
  • Non-Elective Procedures and Prescription Drugs
    • Exhibit 3-2: Average Share of Non-Elective Healthcare Expenses Paid Out-of-Pocket by Percentile of Total Health Spending, 2018 (Top 1st, 1st to 5th, 5th to 10th, 10th to 20th, Lowest 80th)
    • Exhibit 3-3: Average Share of Non-Elective Healthcare Expenses Paid Out-of-Pocket by Type of Service, 2018 (Hospital, Outpatient, Office Based Visit, Prescription Drugs, Emergency Room, Dental, Home Health, Vision, Other Health Care)
    • Exhibit 3-4: Average Share Paid Out-of-Pocket by U.S. Residents by Percentile of Total Health Spending and Type of Service, 2018 (in top 5%: Hospital, Outpatient, Office Based Visit, Prescription Drugs, Emergency Room, Dental, Home Health, Vision, Other Health Care; in top 10% to 5%: Hospital, Outpatient, Office Based Visit, Prescription Drugs, Emergency Room, Dental, Home Health, Vision, Other Health Care; in top 20% to 10%: Hospital, Outpatient, Office Based Visit, Prescription Drugs, Emergency Room, Dental, Home Health, Vision, Other Health Care; in bottom 80%: Hospital, Outpatient, Office Based Visit, Prescription Drugs, Emergency Room, Dental, Home Health, Vision, Other Health Care)
    • Exhibit 3-5: Distribution of Out-of-Pocket Healthcare Spending for the Average Person, 2018 (Hospital, Outpatient, Office Based Visit, Prescription Drugs, Emergency Room, Dental, Vision, Other Health Care)
    • Exhibit 3-6: Drug Cost Coverage by Payor Type (Public, Private, Cash) 1965, 1985, 2000, 2005, 2010, 2018
  • Consumers Who Pay Out-Of-Pocket
    • Exhibit 3-7: Size of High Risk Groups for Out-of-Pocket Healthcare Expenditures, 2014 – 2024, in Millions of Persons (The Uninsured & Under-insured, Medicaid Recipients, The Disabled, Senior Citizens, The Mentally Ill, The Obese, Persons with Drug or Alcohol Addictions, Persons with Chronic Conditions)
    • Exhibit 3-8: Comparative Sizes of High Risk Groups for Out-of-Pocket Healthcare Expenditures, 2014 – 2024, in Millions of Persons (The Uninsured & Under-insured, Medicaid Recipients, The Disabled, Senior Citizens, The Mentally Ill, The Obese, Persons with Drug or Alcohol Addictions, Persons with Chronic Conditions)
  • The Uninsured and Underinsured
  • Medicaid Recipients
  • The Disabled
  • Senior Citizens
  • The Mentally Ill
  • The Obese
    • Exhibit 3-9: Obesity in the United States, 1980 – 2024 (U.S. Population [Millions], Percentage Obese, Number Obese [Millions])
    • Exhibit 3-10: Growth in Obesity in the United States, 1980 – 2024, in Millions of Persons (U.S. Population, Number Obese)
  • Persons with Alcohol and Drug Addictions
  • Persons with Chronic Conditions
    • Exhibit 3-11: Proportion of Adults under Age 65 with Chronic Conditions, 2018 (Privately Insured, Medicare or Medicaid, Uninsured, Other)

Chapter 4: Consumer Out-of-Pocket Spending Forecasts in the U.S.

  • Forecasts
  • Total Expenditures
    • Exhibit 4-1: Consumer Out-of-Pocket Expenditures 2014 – 2024, in $ Billion
    • Exhibit 4-2: Growth of Consumer Out-of-Pocket Expenditures 2014 – 2024, in $ Billion
    • Exhibit 4-3: Drivers & Restraints of Consumer Out-of-Pocket Expenditures
  • Expenditures by Type
    • Exhibit 4-4: Consumer Out-of-Pocket Expenditures by Type 2014 – 2024, in $ Billion (Direct Payments, Co-pays, Total, Change [%])
    • Exhibit 4-5: Change in Consumer Out-of-Pocket Expenditures by Type 2014 – 2024, in $ Billion (Direct Payments, Co-pays)
    • Exhibit 4-6: Proportion of Consumer Out-of-Pocket Spending by Type of Healthcare Expenditure, 2014, 2019, 2024 (Direct Payments, Co-pays)
    • Exhibit 4-7: Drivers & Restraints of Direct Pay and Co-Pay Expenditures
  • Payment Methods
    • Exhibit 4-8: Consumer Out-of-Pocket Expenditure by Payment Type, 2014 – 2024, in $ Billion (Credit Cards, Cash or Check, FSAs, Loans or Lines of Credit, Healthcare Financing Programs, HSAs, Total, Change [%])
    • Exhibit 4-9: Change in Consumer Out-of-Pocket Expenditure by Payment Type, 2014 – 2024, in $ Billion (Credit Cards, Cash or Check, FSAs, Loans or Lines of Credit, Healthcare Financing Programs, HSAs)
    • Exhibit 4-10: Proportion of Consumer Out-of-Pocket Expenditures by Payment Type, 2014, 2019, 2024 (Credit Cards, Cash or Check, FSAs, Loans or Lines of Credit, Healthcare Financing Programs, HSAs)
    • Exhibit 4-11: Drivers & Restraints of Credit Cards, Cash/Check, FSA, Loan/Line of Credit, Healthcare Financing Program and HSA Expenditures
  • Total Financing of Elective vs. Non-Elective Procedures
    • Exhibit 4-12: Consumer Out-of-Pocket Expenditures for Elective vs. Non-Elective Procedures, 2014 – 2024, in $ Billion (Elective, Non-Elective, Total, Change [%])
    • Exhibit 4-13: Growth of Consumer Out-of-Pocket Expenditures for Elective vs. Non-Elective Procedures, 2014 – 2024, in $ Billion (Elective, Non-Elective)
    • Exhibit 4-14: Consumer Out-of-Pocket Expenditures for Elective Procedures That Are Financed, by Payment Type, 2014 – 2024, in $ Billion (Paid by Cash or Check, Financed, Total, Change [%])
    • Exhibit 4-15: Change in Consumer Out-of-Pocket Expenditures for Elective Procedures by Payment Type, 2014 – 2024, in $ Billion (Paid by Cash or Check, Financed)
    • Exhibit 4-16: Proportion of Consumer Out-of-Pocket Spending for Elective Procedures That Are Financed (All Methods), 2014, 2019, 2024 (Paid by Cash or Check, Financed)
    • Exhibit 4-17: Drivers & Restraints of Elective Procedure Out-of-Pocket Expenditures
    • Exhibit 4-18: Amount of Consumer Out-of-Pocket Expenditures for Non-Elective Procedures That Are Financed, 2014 – 2024, in $ Billion (Paid by Cash or Check, Financed, Total, Change [%])
    • Exhibit 4-19: Change in Consumer Out-of-Pocket Expenditures for Non-Elective Procedures by Payment Type, 2014 – 2024, in $ Billion (Paid by Cash or Check, Financed)
    • Exhibit 4-20: Proportion of Consumer Out-of-Pocket Spending for Non-Elective Procedures That Are Financed (All Methods), 2014, 2019, 2024 (Paid by Cash or Check, Financed)
    • Exhibit 4-21: Distribution of Out-of-Pocket Spending on Non-Elective Procedures for the Average Person, 2013 (Ill-defined conditions, Circulatory, Musculoskeletal, Respiratory, Endocrine, Nervous system, Cancers, Injury, Genitourinary, Digestive, Mental Illness, Other, Infectious diseases, Pregnancy and childbirth, Dermatological)
    • Exhibit 4-22: Drivers & Restraints of Non-Elective Procedure Out-of-Pocket Expenditures

Chapter 5: Specialized Healthcare Financing

  • Introduction
  • Improving Collections
  • Market Expansion
  • Customer Satisfaction
  • Types of Procedures Financed
  • Elective Procedures
    • Exhibit 5-1: Share of Medical Procedure Financing Market by Major Segment, 2019 (Cosmetic Surgery, Cosmetic Dentistry, Chiropractic Services, Fertility Treatments, Weight Loss Surgery, Vision Correction, Hair Restoration, Others)
    • Exhibit 5-2: Cosmetic Surgical Procedures Offered in the U.S., 2019 (Invasive, Minimally Invasive, Non- Invasive)
    • Exhibit 5-3: Fertility Treatments Offered in the U.S., 2019 (Approach, Description, Share of Patients [%])
    • Exhibit 5-4: Leading Weight Reduction Surgeries Offered in the U.S., 2019
  • Non-Elective Procedures
  • Industry Exits

Chapter 6: Specialized Healthcare Financing Forecasts

  • Total Expenditures
    • Exhibit 6-1: Consumer Out-of-Pocket Expenditures Paid with Specialized Healthcare Financing 2014 – 2024, in $ Billion
    • Exhibit 6-2: Growth of Consumer Out-of-Pocket Expenditures Paid with Specialized Healthcare Financing 2014 – 2024, in $ Billion
  • Drivers & Restraints
    • Exhibit 6-3: Drivers & Restraints of Specialized Healthcare Financing
  • Elective Procedures
    • Exhibit 6-4: Segmentation of Selected Medical Finance Companies in the U.S., 2019 (Elective Procedures, Non- Elective Procedures, Non-Medical Expenditures)
    • Exhibit 6-5: Consumer Out-of-Pocket Elective Procedure Expenditures Paid with Specialized Healthcare Financing 2014 – 2024, in $ Billion
    • Exhibit 6-6: Growth of Consumer Out-of-Pocket Elective Procedure Expenditures Paid with Specialized Healthcare Financing 2014 – 2024, in $ Billion
  • Drivers & Restraints
    • Exhibit 6-7: Drivers & Restraints of Specialized Healthcare Financing for Elective Procedures
  • Non-Elective Procedures
    • Exhibit 6-8: Consumer Out-of-Pocket Non-Elective Procedure Expenditures Paid with Specialized Healthcare Financing 2014 – 2024, in $ Billion
    • Exhibit 6-9: Growth of Consumer Out-of-Pocket Non-Elective Procedure Expenditures Paid with Specialized Healthcare Financing 2014 – 2024, in $ Billion
  • Drivers & Restraints
    • Exhibit 6-10: Drivers & Restraints of Specialized Healthcare Financing for Non-Elective Procedures
  • Key Players
    • Exhibit 6-11: Leading Providers of Specialized Healthcare Financing in 2019, in $ Billion
    • Exhibit 6-12: Market Positions of Leading Providers of Specialized Healthcare Financing in 2019

Chapter 7: Efforts to Contain Out-of-Pocket Spending

  • Introduction
  • Industry
  • Consumer Education
  • Artificial Intelligence
  • Professional Organizations
  • Government
  • Federal Government
  • State Governments
    • Exhibit 7-1: Recent State Cost Cutting and Payment Reform Legislation
  • Consumer Groups, Community Organizations and Others

Chapter 8: Company Profiles

  • Ajeva
    • History and Lines of Business
    • Financial Information
    • Relevant Business Operations
  • Aurora Quick Care
    • History and Lines of Business
    • Financial Information
    • Relevant Business Operations
  • CareCredit
    • History and Lines of Business
    • Financial Information
    • Relevant Business Operations
  • CareSpot
    • History and Lines of Business
    • Financial Information
    • Relevant Business Operations
  • ClearBalance
    • History and Lines of Business
    • Financial Information
    • Relevant Business Operations
  • ClearGage
    • History and Lines of Business
    • Financial Information
    • Relevant Business Operations
  • Concentra
    • History and Lines of Business
    • Financial Information
    • Relevant Business Operations
  • Denefits
    • History and Lines of Business
    • Financial Information
    • Relevant Business Operations
  • E-Financing Solutions
    • History and Lines of Business
    • Financial Information
    • Relevant Business Operations
  • FastMed
    • History and Lines of Business
    • Financial Information
    • Relevant Business Operations
  • Lending Club Patient Solutions
    • History and Lines of Business
    • Financial Information
    • Relevant Business Operations
  • LendingUSA
    • History and Lines of Business
    • Financial Information
    • Relevant Business Operations
  • MinuteClinic
    • History and Lines of Business
    • Financial Information
    • Relevant Business Operations
  • NextCare
    • History and Lines of Business
    • Financial Information
    • Relevant Business Operations
  • PatientFi
    • History and Lines of Business
    • Financial Information
    • Relevant Business Operations
  • Prosper Healthcare Lending
    • History and Lines of Business
    • Financial Information
    • Relevant Business Operations
  • RediClinic
    • History and Lines of Business
    • Financial Information
    • Relevant Business Operations
  • Reliance Medical Financial
    • History and Lines of Business
    • Financial Information
    • Relevant Business Operations
  • SimpleSelect Patient Finance
    • History and Lines of Business
    • Financial Information
    • Relevant Business Operations
  • S. HealthWorks
    • History and Lines of Business
    • Financial Information
    • Relevant Business Operations
  • Wells Fargo
    • History and Lines of Business
    • Financial Information
    • Relevant Business Operations

 

    Molecular Diagnostics in Oncology, Genetic/Inherited Diseases, and NIPT, 2023-2028
    November 29, 2023
    Remote Patient Monitoring and Telehealth Markets, 13th Edition
    November 27, 2023
    World Market for Laboratory Information Systems (LIS): Software, Hardware, and Implementation for Clinical Labs, 2022-2027
    October 18, 2023
    Out-of-Pocket Spending in Healthcare (Pharmaceuticals, Surgeries, Tests, Electives, Premiums, Copays, Doctor Visits, Other), 6th Edition
    July 13, 2023

Related products

  • Placeholder image

    Healthcare Computer System Markets and Trends in HIT Buying (Forecasts for System, Service and Support Revenues, Areas of interest, major competitor profiles)

    $1,995.00 – $7,000.00
  • Placeholder image

    Healthcare in a Recession (OTC, Generics, Out of Pocket Spending, Healthcare Legislation, Retail Clinics, Outsourcing and Other Topics)

    $500.00 – $3,990.00
  • Placeholder image

    Wireless in Healthcare (Hospital, Physician Office, Pharmaceutical and other Healthcare Markets for Bluetooth, RFID, Zigbee and other technologies)

    $3,500.00 – $7,990.00
  • Placeholder image

    U.S. Market for Home Care Products, 5th Edition

    $2,995.00 – $7,990.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
The Worldwide Market for Point-of-Care (POC) Testing (Infectious Disease Testing,...The 2019 Worldwide Market for Targeted Cancer Therapeutics
Scroll to top